Birmingham, West Midlands -- (SBWIRE) -- 01/23/2014 -- Value Penny Stocks issues special report on Athersys, Inc. (NASDAQ:ATHX), Apollo Investment Corp. (NASDAQ:AINV), IMRIS Inc (NASDAQ:IMRS), Ares Capital Corporation (NASDAQ:ARCC).
Athersys, Inc. (NASDAQ:ATHX) ended its recent business day with the loss of -0.48% and closed at the price of $4.15 after opening at $4.20. The stock traded during its last trading session with the total volume of 1,886,693 shares, as compared to its average volume of 2.25 million shares. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company’s lead platform product, MultiStem, an allogeneic stem cell product, which was evaluated in two completed Phase I clinical trials and is under two ongoing Phase II clinical trials for treating a range of diseases and various application in the field of clinical regenerative medicine.
Has ATHX Found The Bottom and Ready To Move Up? Find Out Here
Apollo Investment Corp. (NASDAQ:AINV) remained among the day advancers and traded with volume of 1,865,338 shares in the last session, as compared to average volume of 1.51 million shares. In comparison with 52 week range of $7.28 - $9.09, it faced lowest price of $8.94 during the last trading session whereas its day highest price was $9.05. The company’s total market capitalization is $2.02 billion, along with 224.74 million shares outstanding. Apollo Investment Corporation is business Development Company and operates as a closed-end management investment company. The company invests in middle market companies. It provides direct equity capital, mezzanine and senior secured loans, and subordinated debt and loans.
Why Should Investors Buy AINV After The Recent Gain? Just Go Here and Find Out
IMRIS Inc (NASDAQ:IMRS) showed 1,843,537 shares in volume during the last trading session, while the average trading volume remained 245,476.00 shares. The stock kicked off its trading session at $1.92 and closed at $2.07 after mounting 7.81%. IMRIS Inc. designs, manufactures, and sells image-guided therapy systems that enable surgeons to obtain information and make decisions during the course of procedures. It offers VISIUS Surgical Theatres, which deliver detailed visual information to clinicians during the course of various traditional surgical procedures, including neurological, cardiovascular, cerebrovascular, interventional, and spine.
For How Long IMRS will Fight for Profitability? Read This Trend Analysis report
Ares Capital Corporation (NASDAQ:ARCC) stock traded during its last trading session with the total traded volume of 1,838,839 shares versus its average volume of 2.43 million shares. The company opened its trade at the price of $18.00 and its closing price was $17.93 after losing -0.11% for the day. Ares Capital Corporation (Ares Capital) is a specialty finance company, which is a closed-end, non-diversified management investment company. The Company’s wholly owned subsidiaries and vehicles managed or sub-managed by its wholly owned portfolio company, Ivy Hill Asset Management, L.P. (IHAM).
Will ARCC Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)